Caribou Biosciences (CRBU) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CRBU Caribou Biosciences

Watchlist

2.680
-0.100-3.60%

Close Nov 8 16:00 ET

2.720
+0.040+1.49%

Post 20:01 ET

242.68MMarket Cap-1614P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Caribou Biosciences' Strategic Advancements and Financial Efficiency Bolster Buy Rating
TipRanksNov 8 02:29 ET · Ratings
Evercore Maintains Caribou Biosciences(CRBU.US) With Hold Rating, Maintains Target Price $3
Moomoo NewsNov 7 09:31 ET · Ratings
Caribou Bioscience GAAP EPS of -$0.38 Beats by $0.06, Revenue of $2.02M Misses by $1.07M
Seeking AlphaNov 7 02:40 ET
Caribou Biosciences, Inc. (CRBU) Reports Q3 Loss, Lags Revenue Estimates
Zacks Nov 6 17:15 ET
Caribou Biosciences | 10-Q: Q3 2024 Earnings Report
SECNov 6 16:14 ET · Announcements
Express News | Caribou Biosciences Reports Third Quarter 2024 Financial Results and Provides Business Update
ReutersNov 6 16:05 ET

Comments

Stock_Drift

Sep 25 08:16

$Caribou Biosciences (CRBU.US)$

FattyChick

Sep 13 12:24

Next 3 stocks keeping an eye on.

$Caribou Biosciences (CRBU.US)$
$Gossamer Bio (GOSS.US)$
$Archer Aviation (ACHR.US)$
Gonna add a position for each again.

Trytosaveabit

Sep 3 07:01

News

$Caribou Biosciences (CRBU.US)$ Reuters· just
Caribou Biosciences Announces the FDA Has Granted Fast Track Designations to CB-010 in Refractory Sle and to CB-012 in Relapsed or Refractory Aml

Jaguar8

Jun 2 20:24

NEWS

$Caribou Biosciences (CRBU.US)$
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Caribou Biosciences presented promising clinical data from its CB-010 ANTLER Phase 1 trial at the 2024 ASCO Annual Meeting. CB-010, an allogeneic CAR-T cell therapy with partial HLA matching, showed potential to rival currently approved autologous CAR-T therapies in safety an...

Trytosaveabit

Apr 16 05:31

Hmm?

$Caribou Biosciences (CRBU.US)$ Got a inverted hammer on the daily! Its wick actually broke above the downtrend continuation wedge! Its Really OS RSI 7 = 14.58! RSI 14 = 24.96! MACD Looks as if its fixing to GC? So lets just see how this turns out? Just thinking outloud

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

Concept

Gene Editing

Intraday+1.71%

CRBU Caribou Biosciences

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target